Neonatal jaundice is a common condition that affects newborns within the first few days of life. It is characterized by yellowing of the skin and eyes due to high levels of bilirubin in the blood. Bilirubin is a waste product that is produced when red blood cells break down. Normally, the liver eliminates bilirubin from the body, but in newborns, the liver is not yet fully developed, and therefore, it may not be able to eliminate bilirubin as efficiently as it should.
There are various causes of neonatal jaundice, and one of them is drugs or toxins transmitted from the mother or given to the newborn. Some drugs and toxins can cross the placenta from the mother to the fetus, and others may be given to the newborn after birth.
Neonatal jaundice due to drugs or toxins transmitted from the mother or given to the newborn can be prevented by avoiding exposure to these substances. Pregnant women should avoid taking drugs or toxins that can harm the fetus, and healthcare providers should carefully consider the risks and benefits of any drugs given to the newborn after birth. Treatment for neonatal jaundice due to drugs or toxins may include phototherapy, which involves exposing the baby's skin to special lights that help break down bilirubin, or in severe cases, exchange transfusion, which involves replacing the baby's blood with donor blood.
In conclusion, neonatal jaundice is a common condition that affects many